Welcoming and opening of the meeting – Tom Øresland


MDT:Consultants Corner 1 – Ebbe Langholz


Treat to target, but what’s the target? – Geert D’Haens


Towards personalized anti –TNF in Crohn’s disease; lessons from the PANTS cohort – Tariq Ahmad


Thiopurines pro – con debate – Jørn Brynskov and Pauliina Molander


Therapeutic drug monitoring in clinical practice – Casper Steenholdt


Satellite Symposium 1 – Janssen


Satellite Symposium 2 -Takeda


Satellite Symposium 3 – Tillotts Pharma


Quality Standards of Care – Susanna Jäghult


Oral presentation of 5 selected posters


New drugs – new targets, losers and winners – Tim Raine


Management of complications of PSC – Annika Bergquist


Is PSC still the black box of Hepatology? What is new in research on etiology? – Espen Melum


How to interpret pharma studies – Jan Marsal


Fibrosis in Crohn’s disease – Gerhard Rogler


Diagnosis and follow-up of patients diagnosed with PSC – Martti Färkkilä


Checkpoint inhibitors and colitis – Michael Eberhardson and Jakob Seidelin


Biomarkers playing a different role in the future – Jonas Halfvarson


Best poster award


Adjourn – Tom Øresland